JPRN-UMIN000048296招募中未知
Phase II clinical trial to evaluate the safety and efficacy of particle radiotherapy preceded atezolizumab plus bevacizumab treatment in patients with unresectable multiple hepatocellular carcinoma - Phase II clinical trial to evaluate the safety and efficacy of particle radiotherapy preceded atezolizumab plus bevacizumab treatment in patients with unresectable multiple hepatocellular carcinoma
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 43
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with multiple cancers. Patients with multiple cancers, but no signs of recurrence for at least 5 years after completion of treatment, and patients with epithelial cancer or endoscopically resectable gastrointestinal cancer within 5 years of completion of treatment may be enrolled. 2.Patients with untreated or poorly treated esophageal and/or gastric varices with or at high risk of bleeding. Patients who have undergone esophagogastroduodenoscopy prior to enrollment and who have been evaluated and treated for all varices, large or small, according to the institution's standard of care, and who are judged to have a low risk of bleeding may be enrolled. 3. Patients who are judged to be inappropriate to participate in this study by the principal investigator or sub-investigator. 4. Patients who are judged to be inappropriate according to the latest practice guideline for the use of atezolizumab/bevacizumab combination therapy. 5. Other patients deemed inappropriate by the study investigators
研究者
相似试验
进行中（未招募）
1 期
Trial to evaluate the safety and efficacy of a research drug in combination with antiretroviral treatment to cure people infected with HIV-1 without antiretroviral treatment.EUCTR2018-000497-30-ESFundación Pública Andaluza para la Gestión en Salud de Sevilla (FISEVI)12
进行中（未招募）
不适用
Clinical phase II trial to evaluate the safety and efficacy of clofarabine and treosulfan conditioning prior to peripheral blood stem cells transplantation in paediatric and adult patients with advanced haematological malignancies - NDpatients affected by advanced haematological malignanciesMedDRA version: 9.1Level: HLGTClassification code 10018865Term: Haematopoietic neoplasms (excl leukaemias and lymphomas)EUCTR2008-006972-31-ITOSPEDALE S. RAFFAELE
进行中（未招募）
1 期
Clinical phase II trial to evaluate the safety and efficacy of treosulfan based conditioning prior to allogenic haematopoietic stem cell transplantation in patients with haematological malignancies. - NDEUCTR2005-005182-11-ITOSPEDALE S. RAFFAELE
进行中（未招募）
1 期
Clinical phase II trial to evaluate the safety and efficacyof treosulfan combined with cytarabine and fludarabine prior to autologous haematopoietic stem cell transplantation in elderly patients withAcute Myeloid Leukemia or Myelodysplastic Syndrome. - NDelderly patients withAcute Myeloid Leukemia or Myelodysplastic SyndromeMedDRA version: 9.1Level: HLTClassification code 10024291Term: Leukaemias acute myeloidEUCTR2008-000664-16-ITOSPEDALE S. RAFFAELE15
进行中（未招募）
1 期
Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive Surgery.CTIS2024-515235-29-00Red Andaluza De Diseno Y Traslacion De Terapias Avanzadas Fundacion Publica Andaluza Progreso Y Salud15